M Ventures
Corporate VCLos Angeles · Seed–Growth · 9 people tracked
Also known as MACRO VENTURES LLC
Investment thesis
Invests in innovative technologies and products that can significantly impact Merck's core business areas.
Source: firm website, verified Jul 28, 2026.
Team · 9 people
from public directories
What they invest in
from 47 of 117 portfolio companiesDeep Tech ×26Biotech ×25AI & Machine Learning ×17Healthtech ×12Semiconductors ×12Medical Devices ×10Hardware ×8Advanced Manufacturing ×5
HQs:United States×26Germany×3Switzerland×2Belgium×1China×1France×1
Investments · 117 tracked
founders shown can be your intro pathBy year:2025 · 22021 · 12019 · 12017 · 26 dated
Xilio (Xilio Therapeutics) is a clinical-stage biotechnology company developing tumor-selective immunotherapies, including checkpoint inhibitors, T cell engagers and related molecules, for the treatment of cancer.
BiotechHealthtechWaltham, US
Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)Rachel Humphrey(Director)Daniel Lynch(Director)Michael Ross(Director)
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.
BiotechDeep TechMedical DevicesCulver City, US
Leroy Hood(Director)Andreas Jurgeit(Director)James Heath(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Douglas Fisher(Director)
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)Robert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)
BioSpace is a platform providing news, job listings, and recruitment marketing solutions for the life sciences industry.
BiotechHealthtechHR TechMarketing TechMedia & EntertainmentMedical DevicesSaaSDes Moines, US
Josh Goodwin(CEO)
Radiopharmaceutical company developing targeted cancer therapies using alpha-particle emitting radionuclides.
Developing The Benchtop Cell Factory, an end-to-end platform for Cell and Gene Therapy manufacturing using microfluidic technology.
The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.
AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US
Preetinder Virk(Chief Operating Officer)David Lazovsky(President and Chief Executive Officer)Kelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)Alexis Bjorlin(Director)
BoardLip-Bu Tan(Director)
ChEmpower develops an abrasive-free, environmentally sustainable chemical-mechanical planarization (CMP) process and consumables such as polishing pads for semiconductor fabrication, aiming to increase chip yields, simplify fab processes, and recycle water and recover metals.
CleantechNew MaterialsSemiconductorsBeaverton, US
SUDHANSHU MISRA(Executive Officer, Director)Sudhanshu Misra(CEO)SV Babu(CTO)
BoardSCOTT SHAW(Director)OWEN LOZMAN(Director)JESSICA FREYER(Director)
Concerto develops microbial ecology data and AI tools to engineer microbe-based products for consumer health applications including skincare, chronic disease, and nutrition.
AI & Machine LearningBiotechDeep TechCambridge, US
Vera Schroeder(Director)Jared Kehe(Executive Officer, Director)Cheri Ackerman(Executive Officer, Director)Bernardo Cervantes(Executive Officer, Director)
BoardSarah Luppino(Director)
Disco Pharmaceuticals develops cancer therapies using a cell surfaceome discovery technology to identify new molecular targets.
BiotechHealthtech
Electroninks develops metal complex conductive inks for semiconductor packaging, printed circuit boards, consumer electronics, and wearables that achieve conductivities up to 90% of bulk metal at low annealing temperatures.
Advanced ManufacturingNew MaterialsSemiconductorsAustin, US
IKAS builds AI and modeling-based industrial intelligent manufacturing solutions for companies across the semiconductor supply chain (chip design, wafer fabrication, packaging and testing, equipment, and materials) as well as the power and energy sector.
Advanced ManufacturingAI & Machine LearningSemiconductorsBeijing, CN
ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Alicia Jackson(Director)Stuart Alexander Jacobson(Executive Officer, Director)Gregory A. Bonfiglio(Director)Peretz Partensky(Executive Officer, Director)Mary Kim Warren(Director)Nina Horowitz(Chief Executive Officer)
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)Juergen Eckhardt(Director)
BoardLaura Brass(Director)
iOmx is a clinical-stage biotech company developing targeted cancer immunotherapies for common solid tumor indications, translating tumor immune evasion biology into biomarker-enabled drug programs.
BiotechHealthtech
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)Lars van der Veen(Co-Founder & CSO)Michael Lahn(CMO)Elizabeth Holt(CBO)Steven Sciuto(CFO)Michelle Tsai(COO)
IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.
Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE
Bene(Co-Founder & Managing Director)Monty(Co-Founder & Managing Director)
BiotechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Executive Officer, Director)
LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.
AI & Machine LearningBiotechDeep Tech
Exits · 3
IPOs and acquisitions across the tracked portfolioProgynyNASDAQ: PGNYXilio TherapeuticsNASDAQ: XLOTranslate Bioacq. by Sanofi
Portfolio news
latest coverage across their companiesLightcast · kb.lightcast.io · Jul 2, 2026
Wiliot · finsmes.com · Apr 28, 2026
Neurable · businesswire.com · Apr 28, 2026
Anjuna · techcrunch.com · Apr 9, 2026
Metalenz · trysignalbase.com · Mar 25, 2026
Vizgen · intelligence360.news · Feb 2, 2026
Frequently asked questions
- What stage does M Ventures invest at?
- M Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is M Ventures's typical check size?
- M Ventures typically writes checks of $10.8M.
- What sectors does M Ventures focus on?
- M Ventures focuses on Biotech, Hardware, Healthtech, IoT, Medical Devices, New Materials.
- Where is M Ventures located?
- M Ventures is headquartered in Los Angeles, US.
- Does M Ventures lead rounds?
- M Ventures typically participates in rounds rather than leading them.
Co-investors · 11
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
SV Health Investors is a healthcare-focused private equity and venture capital investment platform managing specialized and diversified funds across biotechnology, healthcare growth equity, and medtech.
Insight Partners is a venture and growth-stage software investor featuring a large portfolio of technology companies across multiple sectors and regions.
Agent Capital is a healthcare venture capital firm that invests in novel, differentiated therapeutics and treatments addressing unmet patient needs across all stages of development.
Buff Gold Ventures is an investment firm that funds deep tech startups emerging from the University of Colorado, backing CU Boulder faculty, students, alumni, and companies licensing CU intellectual property.
Bain Capital Ventures is the venture arm of Bain Capital, backing founders from incubation and seed through growth-stage, leveraging Bain Capital's global platform, industry expertise, and network.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
eCAPITAL is a venture capital firm providing funding from early to growth stage to technology companies across software and IT, cybersecurity, industry 4.0, new materials, and cleantech.
AbbVie Ventures is the corporate venture capital arm of biopharmaceutical company AbbVie, investing in early-stage companies in oncology, immunology, and neurodegenerative diseases that complement the parent company's research and development pipeline.
Firms observed investing alongside M Ventures, from public investor directories. Shared companies are the overlap with M Ventures's recorded portfolio.
Similar investors
Oxford Investment Consultants (OIC) backs founders commercialising scientific research from Oxford University and other leading UK research institutions, managing the Oxford Technology and Innovations EIS Fund (OTIF).
Industrial Technology Investment Corporation is the venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), backing startups across multiple stages and sectors while providing access to ITRI's R&D resources.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
Amplitude Ventures is a Canadian healthcare venture capital firm focused on precision medicine, founded by former BDC partners Dion Madsen and Jean-François Pariseau. BDC Capital is an investor in its Fund I.
Asahi Kasei Corporate Venture Capital, established in 2008, invests in innovative global companies across materials, homes, and healthcare sectors. The firm identifies strategic opportunities aligned with Asahi Kasei's core business, with offices in Menlo Park, Boston, Düsseldorf, and Shanghai.